Why BG Medicine (BGMD) Stock Is Plunging Today

NEW YORK (TheStreet) -- BG Medicine  (BGMD) plunged Wednesday after the diagnostics company reported first-quarter results that came up short of analysts' expectations.

The company reported a loss of 8 cents a share, which aligned with the estimate of a loss of 8 cents a share. Revenue totaled $739,000, which came up short of the estimate of $1.3 million.

The stock was down 15.75% to $1.07 at 1:46 p.m.

Must Read: Warren Buffett's 10 Favorite Growth Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BGMD Chart

BGMD data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

What Is a Bear Market and What Does it Mean in 2018?

What Is a Bear Market and What Does it Mean in 2018?

Seaworld, Ex-CEO Settle With SEC; Keys to Alibaba Growth -- ICYMI

Seaworld, Ex-CEO Settle With SEC; Keys to Alibaba Growth -- ICYMI

The Products Behind the Smokin' Hot Tilray

The Products Behind the Smokin' Hot Tilray

Dow, Stocks Shrug Off Trade War Escalation, End Higher

Dow, Stocks Shrug Off Trade War Escalation, End Higher

Tariffs 'Create Uncertainty' for Global Free Trade, TE Connectivity Chief Says

Tariffs 'Create Uncertainty' for Global Free Trade, TE Connectivity Chief Says